Surrozen (SRZN) Competitors $13.09 -0.35 (-2.60%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SRZN vs. OCAX, INMB, PDSB, RANI, IVVD, IMUX, IPSC, ANIX, ME, and DERMShould you be buying Surrozen stock or one of its competitors? The main competitors of Surrozen include OCA Acquisition (OCAX), INmune Bio (INMB), PDS Biotechnology (PDSB), Rani Therapeutics (RANI), Invivyd (IVVD), Immunic (IMUX), Century Therapeutics (IPSC), Anixa Biosciences (ANIX), 23andMe (ME), and Journey Medical (DERM). Surrozen vs. OCA Acquisition INmune Bio PDS Biotechnology Rani Therapeutics Invivyd Immunic Century Therapeutics Anixa Biosciences 23andMe Journey Medical OCA Acquisition (NASDAQ:OCAX) and Surrozen (NASDAQ:SRZN) are both small-cap unclassified companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings. Which has higher earnings & valuation, OCAX or SRZN? OCA Acquisition has higher earnings, but lower revenue than Surrozen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOCA AcquisitionN/AN/A-$2.48MN/AN/ASurrozen$12.50M3.36-$43.04MN/AN/A Is OCAX or SRZN more profitable? OCA Acquisition's return on equity of 0.00% beat Surrozen's return on equity.Company Net Margins Return on Equity Return on Assets OCA AcquisitionN/A N/A -7.58% Surrozen N/A -105.45%-69.39% Does the media favor OCAX or SRZN? In the previous week, OCA Acquisition had 1 more articles in the media than Surrozen. MarketBeat recorded 1 mentions for OCA Acquisition and 0 mentions for Surrozen. OCA Acquisition's average media sentiment score of 0.00 equaled Surrozen'saverage media sentiment score. Company Overall Sentiment OCA Acquisition Neutral Surrozen Neutral Which has more volatility and risk, OCAX or SRZN? OCA Acquisition has a beta of -0.01, indicating that its stock price is 101% less volatile than the S&P 500. Comparatively, Surrozen has a beta of 0.94, indicating that its stock price is 6% less volatile than the S&P 500. Does the MarketBeat Community prefer OCAX or SRZN? Surrozen received 3 more outperform votes than OCA Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformOCA AcquisitionN/AN/ASurrozenOutperform Votes316.67%Underperform Votes1583.33% Do analysts prefer OCAX or SRZN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OCA Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ASurrozen 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do insiders and institutionals hold more shares of OCAX or SRZN? 38.2% of OCA Acquisition shares are owned by institutional investors. Comparatively, 66.6% of Surrozen shares are owned by institutional investors. 48.9% of OCA Acquisition shares are owned by insiders. Comparatively, 43.5% of Surrozen shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryOCA Acquisition beats Surrozen on 5 of the 9 factors compared between the two stocks. Ad Market Moving TrendsDon't Miss Out: Top 5 Nasdaq Stocks to Buy Now!Nasdaq has a solid track record of beating estimates. Return on equity, reflecting the company's efficiency in utilizing shareholders' funds, was 19.3% in the trailing 12 months, better than the industry average of 13.1%. Are you ready to elevate your investment strategy with the top-performing stocks on the Nasdaq?[Click Here to Automatically Download Your Free eBook Now] Get Surrozen News Delivered to You Automatically Sign up to receive the latest news and ratings for SRZN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRZN vs. The Competition Export to ExcelMetricSurrozenBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$42.02M$3.15B$5.54B$8.53BDividend YieldN/A1.77%5.13%4.14%P/E RatioN/A11.73114.8115.14Price / Sales3.36397.851,495.55100.10Price / CashN/A148.6639.6734.08Price / Book0.714.024.665.02Net Income-$43.04M-$42.25M$119.06M$225.46M7 Day Performance31.03%8.04%0.80%0.37%1 Month Performance19.22%8.69%5.65%3.57%1 Year Performance100.52%32.09%36.75%29.43% Surrozen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRZNSurrozen2.0611 of 5 stars$13.09-2.6%N/A+113.9%$42.02M$12.50M0.0042OCAXOCA AcquisitionN/A$11.22+0.6%N/AN/A$75.58MN/A0.00147,000INMBINmune Bio2.5574 of 5 stars$6.41+18.3%$20.00+212.0%-14.6%$126.66M$160,000.00-3.1110Short Interest ↑News CoverageGap UpHigh Trading VolumePDSBPDS Biotechnology0.8486 of 5 stars$3.34+7.1%$14.25+326.6%-23.4%$122.98MN/A-2.7420Analyst UpgradeRANIRani Therapeutics3.1035 of 5 stars$2.29-2.1%$11.71+411.5%+20.9%$122.31M$2.72M-1.94110Gap UpHigh Trading VolumeIVVDInvivyd2.4939 of 5 stars$1.02+4.7%$11.33+1,011.1%-37.9%$121.70M$2.26M-0.56100Analyst ForecastNews CoverageIMUXImmunic2.5679 of 5 stars$1.35-3.2%$11.20+732.7%+14.4%$121.16MN/A-0.9070News CoverageIPSCCentury Therapeutics1.768 of 5 stars$1.43+2.9%$12.75+791.6%-15.4%$120.84M$2.04M-0.70170Positive NewsANIXAnixa Biosciences2.5821 of 5 stars$3.77+16.0%$7.00+85.7%+14.7%$120.66M$210,000.00-9.675News CoveragePositive NewsGap UpHigh Trading VolumeME23andMe1.9247 of 5 stars$4.85+3.9%$9.40+93.8%-71.6%$118.87M$219.64M-0.19770DERMJourney Medical3.4338 of 5 stars$5.86+1.7%$9.38+60.0%N/A$117.28M$77.68M-293.0090Upcoming EarningsShort Interest ↓ Related Companies and Tools Related Companies OCAX Competitors INMB Competitors PDSB Competitors RANI Competitors IVVD Competitors IMUX Competitors IPSC Competitors ANIX Competitors ME Competitors DERM Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SRZN) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Surrozen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Surrozen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
